A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists

被引：0
|
作者：
Cassandra M. Townsend
Reena Khanna
Aze Suzanne Wilson
机构：
[1] Western University,Division of Gastroenterology, Department of Medicine
[2] Western University,Division of Clinical Pharmacology, Department of Medicine
[3] Western University,Department of Physiology and Pharmacology
来源：
Digestive Diseases and Sciences | 2021年 / 66卷
关键词：
Ulcerative colitis; Crohn’s disease; Inflammatory bowel disease; Tumor necrosis factor-; antagonists; Non-melanoma skin cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4436 / 4440
页数：4
相关论文
共 50 条
  • [21] Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease
    Gareb, Bahez
    Otten, Antonius T.
    Frijlink, Henderik W.
    Dijkstra, Gerard
    Kosterink, Jos G. W.
    PHARMACEUTICS, 2020, 12 (06) : 1 - 31
  • [22] Association of Inflammatory Bowel Disease With Melanoma and Non-melanoma Skin Cancers- A Nationwide Study
    Patel, Pranav
    Kothari, Aditi
    Santhosh, Sanjana
    Lakshmi, Vinthala Kanaka Maha
    Parambil, Mohamed
    Akshara, Boyapati Sayee Sree
    Hasan, Nahid
    Ilkalwale, Madiha
    Duc, Huy
    Nwanguma, Adaugo
    Berhane, Asmeret
    Zhang, Gaoli
    Oza, Jay
    Kanwal, Vishal
    Gujariya, Hetal
    Budh, Deepa
    Patel, Urvish
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S27 - S27
  • [23] Cumulative Risk of Non-Melanoma Skin Cancer in a Population-Based Cohort of Inflammatory Bowel Disease
    Yadav, Siddhant
    Harmsen, William
    Zinsmeister, Alan
    Tremaine, William
    Loftus, Edward
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S654 - S654
  • [24] Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update
    Leso, Veruscka
    Leggio, Lorenzo
    Armuzzi, Alessandro
    Gasbarrini, Giovanni
    Gasbarrini, Antonio
    Addolorato, Giovanni
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (07) : 779 - 786
  • [25] Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease
    Ordas, Ingrid
    Feagan, Brian G.
    Sandborn, William J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (10) : 1079 - 1087
  • [26] Erythema nodosum, malignant melanoma and non-melanoma skin cancer in relation to inflammatory bowel disease: a Mendelian randomization study
    Zhao, Yang
    Shao, Yifan
    Zhou, Jing
    Pei, Jianing
    Chong, Jinchen
    Lu, Changye
    Chen, Yugen
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [27] Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti-Tumor Necrosis Factor Therapy
    Rahier, Jean-Francois
    Buche, Sebastien
    Peyrin-Biroulet, Laurent
    Bouhnik, Yoram
    Duclos, Bernard
    Louis, Edouard
    Papay, Pavol
    Allez, Matthieu
    Cosnes, Jacques
    Cortot, Antoine
    Laharie, David
    Reimund, Jean-Marie
    Lemann, Marc
    Delaporte, Emmanuel
    Colombel, Jean-Frederic
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (12) : 1048 - 1055
  • [28] Comparative Risk of Serious Infections With Tumor Necrosis Factor-α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases
    Singh, Siddharth
    Heien, Herbert
    Herrin, Jeph
    Dulai, Parambir S.
    Sangaralingham, Lindsey
    Shah, Nilay
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S444 - S445
  • [29] The Risk of Tuberculosis in Korean Patients with Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-α Blockers
    Byun, Ja Min
    Lee, Chang Kyun
    Rhee, Sang Youl
    Kim, Hyo-Jong
    Kim, Jung-Wook
    Shim, Jae-Jun
    Jang, Jae Young
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (02) : 173 - 179
  • [30] RECURRENCE OF NON-MELANOMA SKIN CANCER (NMSC) IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS RECEIVING ANTI-TNF MEDICATIONS
    Trivedi, Chinmay
    Kavani, Himanshu
    Khan, Nabeel H.
    GASTROENTEROLOGY, 2018, 154 (06) : S363 - S363
12345